The P2-adrenergic receptor (32AR) can be constitutively activated by mutations in the third intracellular loop. Whereas the wild-type receptor exists predominantly in an inactive conformation (R) in the absence of agonist, the mutant receptor appears to spontaneously adopt an active conformation (R*). We now demonstrate that not only is the mutant I32AR constitutively active, it is also constitutively desensitized and down-regulated. To assess whether the mutant receptor can constitutively engage a known element of the cellular desensitization machinery, the receptor was purified and reconstituted into phospholipid vesicles. These preparations retained the essential properties of the constitutively active mutant receptor: agonist-independent activity [to stimulate guanine nucleotide-binding protein (G5)-GTPase] and agonist-specific increase in binding affinity. Moreover, the purified mutant receptor, in the absence of agonist, was phosphorylated by recombinant PAR-specific kinase (PARK) in a fashion comparable to the agonist-occupied wild-type receptor. Thus, the conformation of the mutated receptor is equivalent to the active conformation (R*), which stimulates G, protein and is identical to the PJARK substrate.
Receptor activation by agonists is the first step in signal transduction. It is generally considered that receptors exist in an equilibrium between an inactive (R) and an active (R*) conformation. The binding of agonists to receptors stabilizes, and therefore shifts, the equilibrium toward the active conformation R* (1, 2). Adrenergic receptors (ARs) provide a model for the family of guanine nucleotide-binding protein (G protein)-coupled receptors (3) , and some recent studies have provided evidence supporting this two-state model of receptor activation: mutations in the C-terminal portion ofthe third intracellular loop of the alB- (4, 5) , (3-(6) , and a2AR subtypes (7) constitutively activate these receptors, leading to an agonist-independent activation of the corresponding effector enzymes. The properties of such constitutively active mutant (CAM) receptors have been rationalized by assuming that they preferentially adopt the active rather than the inactive conformation and therefore spontaneously mimic an agonistoccupied form of the receptor (6) .
In addition to cellular activation, the binding of agonists to cell surface receptors often results in a waning of cellular responsiveness (desensitization). In the well-studied 132-adrenergic system, such attenuation operates mainly at the level of the receptor itself. Indeed, besides the activation of adenylyl cyclase (AC) through the G, protein, the binding of an agonist results in both receptor loss (down-regulation) and receptor uncoupling from the G protein (8) . Uncoupling from the G protein results mainly from the receptor being phosphorylated by two kinases, cAMP-dependent protein kinase and (3-adrenergic receptor-specific kinase (PARK) (9) .
Inasmuch as a CAM receptor mimics an agonist-occupied form of the receptor with respect to cellular activation mechanisms, it might therefore also be expected to constitutively engage the attenuation mechanisms that are normally activated only by occupation of the wild-type (WT) receptor by an agonist. To test this hypothesis, we have taken two complementary approaches: (i) the signal transduction properties of the WT and CAM 32-adrenergic receptor (P32AR)
were assessed in stably transfected mammalian cells, and (ii) the molecular mechanisms underlying these properties were studied with purified and reconstituted preparations of these receptors.
MATERIALS AND METHODS
Permanent Cell Lines. Establishment and maintenance of clones permanently expressing the WT and CAM P2AR in the Chinese hamster ovary (CHO) cell line, cell membrane preparation, determination of receptor density, and AC assays were performed and analyzed as described (6) .
AC Data Analysis. Sensitization was quantitated as the gain of signal transduction efficacy, as detailed earlier (10) . In brief, after subtraction of basal activity, the concentrationresponse curves of control and treated membranes were fitted and compared by using the following algorithm (11):
where E is the effect, Em is the maximal possible effect, A is the agonist concentration, K. is the association constant of the agonist-receptor complex, and n is a slope factor, which was never significantly different from 1 in all experiments presented here. X is a parameter describing the signal transduction efficacy of the system and is estimated individually for each curve, whereas all the other parameters are shared for each pair of treated/control curves. When Tteated > Tcontrol, Ttreated/Tcontrol is taken as a measure of sensitization (-fold (NEN) . WT and CAM (2AR were prepared from Sf9 cells as described (13) . Briefly, receptors were solubilized in 20 mM Tris HCl, pH 7.5/1.5% digitonin/100 mM NaCl/2 mM EDTA, purified on an alprenolol-Sepharose column, reconstituted in phosphatidylcholine vesicles as described (14) , and stored at -700C. NaCl/0.05% digitonin. Bound and free radioligand were separated by G-50 gel-filtration columns. All binding data were subjected to nonlinear least-squares regression analysis (15) .
Radblolgand
GTPase Assay. Heterotrimeric G, protein was purified as described (16) . Purified P2AR (100 fmol) and G, protein (50 fmol) were co-reconstituted in phospholipid vesicles, and receptor-mediated GTPase activity was determined as described (14) .
Receptor Phosphorylation. Recombinant PARK was purified from baculovirus-infected Sf9 cells as described (17) . The reconstituted receptors were phosphorylated by BARK as described (18) or vehicle only (solid curve). Cell membranes were prepared as described (6) with the following modifications: lysis buffer (5 mM Tris HCl, pH 7.5/2 mM EDTA) was supplemented with 10 pM betaxolol for cell lysis and the first rinse ofthe membrane fraction. Samples were then subjected to three more sedimentation-resuspension cycles in lysis buffer devoid ofbetaxolol and subsequently assayed for AC activation by isoproterenol. Data were normalized to the activity evoked by 100 pM forskolin (-25 pmol per min per mg of membrane protein). Solid curve, EC50 = 100 nM; dashed curve, ECso = 63 nM. Control and betaxolol-treated set of data were also compared to yield the increase of T that gauges the enhancement of cyclase responsiveness (see Materials stopped with an equal volume of 2x SDS sample loading buffer and electrophoresed on SDS/10%o polyacrylamide gels. Phosphorylation stoichiometries were determined either by excising and counting the receptor bands or by using a PhosphorImager (Molecular Dynamics) as described (19) .
RESULTS AND DISCUSSION
To test the hypothesis that constitutively active receptors might also be constitutively desensitized, we sought means of reversing the constitutive activity of the 32-CAM receptor (Fig. 1) . Betaxolol (a gift from Synthelabo, Bagneux, France), a ,31-adrenergic antagonist, was found to repress this basal activity (20) . Incubation of cells expressing the CAM receptor with betaxolol at the saturating concentration of 10 ,uM for 17 hr led to both up-regulation of the receptor (Fig.   2 Inset) and sensitization of 8AR-coupled AC, as indicated by a simultaneous increase in basal and maximal activities (Fig. 2) . No such effects were observed for the WT receptor exposed to similar treatment (data not shown).
We next examined the respective contributions of the increase in receptor density and the increase of receptor coupling efficiency to the increase of AC responsiveness. A numerical analysis was applied to the AC dose-response curves, yielding estimates for a parameter (T) that gauges variations of receptor-mediated cyclase activity (see Materials and Methods). The betaxolol treatment resulted in a 6.2 + 0.2-fold sensitization of AC, while the binding site density increased concomitantly by only 2.0 + 0.2-fold (mean + SEM; n = 3; Fig. 2) . Thus, AC sensitization in the presence ofthe negative antagonist reflects an increase ofreceptor/AC coupling in addition to receptor up-regulation. Moreover, the treatment of cells with betaxolol, which increases the sensitivity of AC to an adrenergic agonist, had no effect on the sensitivity of AC to NaF and forskolin (direct activators of the G protein and the catalytic moiety of cyclase, respectively; data not shown). Thus, the CAM receptor in its native state is both tonically down-regulated and partially uncoupled from the G protein.
These findings suggest that the CAM P2AR is able to tonically engage not only G, protein but also various components ofthe cellular desensitization machinery. To test this hypothesis, we examined the role of a well-defined element of this machinery: BARK-mediated phosphorylation of the receptor (9) . We first sought to obtain purified preparations of both WT and CAM receptors for the purpose of comparative studies.
The receptors were expressed in Sf9 cells by infection with recombinant baculoviruses. Expression levels for the mutant were =3 pmol per mg of membrane protein, as compared to 5-10 pmol per mg of membrane protein for the WT 32AR.
Both receptors were purified and reconstituted into phospholipid vesicles (see Materials and Methods). The reconstituted mutant 832AR had a 20-fold higher affinity than the WT receptor for the agonist isoproterenol, whereas both receptors had identical affinities for the antagonist alprenolol (Fig. 3A) , in keeping with our previous observations in membranes (6) . Reconstitution of both receptors with purified G, protein yielded agonist-stimulated GTPase activities (Fig. 3B) . However, the agonist-independent GTPasestimulating activity of the CAM f2AR was comparable to the agonist-dependent activity of the WT receptor. This finding reproduces what we previously observed at the level of AC stimulation for receptors in membranes (6) . Controls with receptors alone indicated the absence of contaminating GTPase activity in the receptor preparations (data not shown). Thus, the purified CAM P2AR exhibits the two major properties of CAM receptors in membranes: (i) agonistspecific, G-protein-independent affinity increase (Fig. 3A) and (ii) elevated agonist-independent signaling activity ( P2AR (100 fmol) was reconstituted with 50 fmol of G. protein as described (14) and preincubated on ice for 20 min in the absence or presence of 100 A&M isoproterenol. Activation was conducted at 300C
for 20 min. Receptor-independent activity of the G protein, determined after reconstitution with heat-inactivated receptors, was subtracted from all measurements. The agonist-independent (basal) activity of the WT receptor was then taken as 100%o. 3B). This indicates that purified preparations of the CAM P2AR can be used to investigate the molecular basis of constitutive desensitization.
We proceeded to assess SARK-mediated phosphorylation of the purified receptors. As was previously observed (21), little if any phosphorylation of the WT receptor occurs in the absence of the agonist isoproterenol (Fig. 4A) . However, the CAM receptor shows considerable phosphorylation under the same conditions (Fig. 4A) . The rate and extent of the agonist-independent phosphorylation ofthe CAM P2AR were comparable to the agonist-dependent phosphorylation of the WT P2AR (Fig. 4B) . The maximal phosphorylation of the CAM 32AR in the presence of isoproterenol was about twice that of the WT P2AR (Fig. 4B) . However, in the presence of purified G-protein fBy subunits, which greatly enhance A2AR phosphorylation by PARK (17) The properties of these mutants have been rationalized within a theoretical model of receptor activation that involves an allosteric transition between two putative conformations of the receptor: one inactive (R), and the other (R*) capable of activating the G protein (6) . Constitutively activating mutations were assumed to make the R to R* transition agonist independent. However, the molecular nature of the hypothetical active conformer R* has remained to be defined.
We confirm here that the activation properties of the mutant receptor are conserved throughout purification and reconstitution procedures. Furthermore, we demonstrate that the ligand-free CAM N2AR has molecular properties close to those of an agonist-occupied WT receptor. One such property is the susceptibility to 3ARK-mediated phosphorylation (19) . The CAM receptor indeed undergoes PARK-mediated phosphorylation even in the absence of agonist. The finding that the agonist-independent phosphorylation of the CAM receptor closely matches the agonist-induced phosphorylation of the WT receptor parallels our observation of the corresponding G,-activating (this work) and AC-stimulating (6) activities. In addition, we have previously shown that when transfected in COS-7 cells, various CAM a2ARs are subject to PARK-mediated, agonist-independent phosphorylation in proportion to their constitutive activity (7) . Taken together, these findings suggest that constitutive activation and susceptibility to PARK-mediated phosphorylation have the same molecular basis. Thus, the results with the purified CAM P2AR strengthen the idea that the postulated R* conformer is equivalent to the PARK substrate.
